SIGA under investigation after release of NYC’s ex-COVID czar’s comments on vaccine

The former employer of a former New York City coronavirus czar appears to have yelled at an unidentified woman, saying the company hired him to “spread” facts about a monkeypox drug made by his company to the media. The company is being investigated for possible violations of federal securities laws.

Two New York City-based law firms this week represented investors after Dr. Jay Varma, former chief medical officer and executive president of SIGA Technologies, was caught making statements on a hidden camera. An investigation has been launched against SIGA Technologies.

Varma, who served as a senior health advisor to former Mayor Bill de Blasio, recalled SIGA's monkeypox drug TPOXX and accused him of using the media to “fabricate a story” to maintain the company's stock price. That seems to be the case, Levi and Korsinski said. A law firm is investigating.

A highly edited clip of a secret recording between Varma and a so-called secret agent was released Wednesday as part of conservative podcaster Steven Crowder's series “Mag Club.”

Another law firm investigating potential collateral claims on behalf of SIGA investors (Wolf, Haldenstein, Adler, Freeman & Hertz) said the company had evaluated the efficacy and safety of TPOXX in treating Mpox. He pointed out that the company was conducting a clinical trial.

However, a clinical trial on Aug. 15 revealed that the drug “failed to meet its primary endpoint,” Wolf-Hardenstein Adler Freeman & Hertz said.

According to Wolf, Haldenstein, Adler, Freeman & Hertz, Varma said the “spin” campaign was apparently carried out to persuade investors “not to sell their shares because they think the company is worthless.” He is said to have said that.

SIGA's stock price fell more than 15% after Varma's comments, the law firm said.

While serving as the city's coronavirus czar at the height of the pandemic, Varma was discovered in secret recordings in which he publicly bragged about hosting sex parties and attending underground Manhattan rave parties. As a result, he was fired from SIGA on September 19th.

He was also removed from the pharmaceutical company's board of directors.

SIGA issued a statement on Wednesday calling Varma's comments “inaccurate and misleading.”

“We are deeply offended by his comments and actions, which do not reflect SIGA, our way of doing business, or our values.” Mr. Shiga said.

“He no longer has any association with SIGA.”

“His recent comments regarding SIGA and TPOXX express his personal views and relate to areas of our business for which he had no responsibility during the year he spent as a SIGA employee.” The statement continued.

The edited clip of Varma was reportedly shot with a hidden camera and recorded from July 27 to August 14 in New York City.

In the second video, Varma explained the Food and Drug Administration's approval process while discussing SIGA Technologies' “Tecobilimat” or “TPOXX” drug.

“That's why it's helpful to bring this issue up in the media. We want the FDA to approve our drug, especially the monkeypox drug, which at this point can only be considered experimental. “The FDA won't approve it,” he said.

In the United States, TPOXX is not approved by the FDA as a treatment for Mpox, but it can be used to treat patients as part of a clinical trial known as the Study of Tecobirimat Against Human Mpox Virus (STOMP), the journal said. are. Shiga Technologies.

The company's website added that the STOMP trial is being conducted to evaluate the efficacy of TPOXX in treating Mpox.

In a video shot on Aug. 14, Varma said his then-employer was “stuck with our drug,” but that people “don't have as much confidence in the drug because the data doesn't seem to be as strong.” I'll never have one,” he complained.

“Sometimes you do research and it doesn't work at all or people get really sick,” he said in a secret recording.

“The problem is, if you do another study, it takes a year or two. You have to get ethics approval, you have to get funding, and patients have to come.”

In the video, Varma smiles at how he “knows reporters very well,” referring to the September report. New York Times interview Regarding Mpox, we promoted TPOXX as a drug used to treat Mpox infections.

Varma also discussed the World Health Organization's “emergency authorization” process before explaining how he would like the media to cover TPOXX.

“Basically, what we're trying to get the media to say is, 'Oh, that drug didn't work because it was designed the wrong way.'” So they do another study. 'And in the meantime, people just prescribe it as an emergency drug. That's what we want for this story,” he said in the edited clip.

Varma added that the risk of Mpox spreading in the United States is “very low” and “will almost certainly remain among gay men.”

“[Mpox] It basically entered the sexual network of gay men…and because many gay men have a ton of sexual partners and often don't use condoms, it spreads more easily.” The doctor previously boasted that he hosted a 10-person sex party during the pandemic.

It was not clear the identity of the woman Varma was talking to or where he met her. The nature of their relationship was also not clear.

Additional reporting by Aneeta Bhole